Our products
For medical information request or pharmacovigilance, please contact : pharmacovigilance@cemagcare.com
Nexag
MEDICAL PRODUCT
Tranexamic acid
For more information :
contact@haima.fr
Yanae
MEDICAL DEVICE
Intrauterine contraceptive device (IUD) copper 380
For more information :
yanae.formation@cemagcare.com
Cinesteam
Medical device
Secondary, absorbent anti-odour dressing with cinnamon.
Designed to manage malodourous wounds.
For mor information :
contac@cinesteamcare.com
Aspirator DVS-S10 and Ipas EasyGrip cannulae
Medical device
Double-Valve Aspirator
Uterine aspiration/uterine evacuation in obstetrics and gynecologic patients.
Ascofer
medicinal product
Ferrous ascorbate
Our projects
MEDICINAL PRODUCT – Periods
Management of painful periods
Dysmenorrhea affects between 45% and 97% (1) of women worldwide.
Well-known treatments, such as NSAIDs and hormonal contraception, are most often accompanied by adverse effects, while other available options often prove ineffective.
We believe that women deserve to experience pain-free menstruation.
CEMAG Care’s aim is to provide an effective medical solution for menstrual pain that is easily accessible and has minimal impact on women’s bodies.
MEDICINAL – CONTRACEPTION
Early menstrual induction
Emergency contraception (EC) offers an effective solution in case of unprotected intercourse. However, it must be used within a 3 to 5-day window following the intercourse.
Onwards, womxn must wait for menstrual periods and take a pregnancy test prior being able to take appropriate measures.
We aim to identify a new option for womxn who out passed the EC time. This new option would allow to induce very early menstruations. CEMAG Care collaborates with Concept Foundation (Switzerland), WHO HRP, and Chulalongkorn University (Thailand) in this project.
ABORTION
Facilitate access to abortion
Abortion has always been an integral part of CEMAG Care’s business, and we strive to meet the specific health needs of women.
The founder of CEMAG Care and his team have recently entered into a major partnership with ACME Laboratories Ltd (pharmaceutical manufacturer) and Concept Foundation (international non-profit organization).
The aim of this joint initiative is to develop a combipack combining Mifepristone and Misoprostol, the two molecules required for medical abortion.
The aim of this project is to promote patient autonomy while offering a solution in line with current medical guidelines.